Literature DB >> 17375905

4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships.

Bente Frølund1, Lars S Jensen, Signe I Storustovu, Tine B Stensbøl, Bjarke Ebert, Jan Kehler, Povl Krogsgaard-Larsen, Tommy Liljefors.   

Abstract

A series of 4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists have been synthesized and pharmacologically characterized. The meta-phenyl-substituted compounds 9k and 9m and the para-phenoxy-substituted compound 9l all display high affinities (Ki=10-70 nM) and antagonist potencies in the low nanomolar range (Ki=9-10 nM). These potencies are significantly higher than those of previously reported 4-PIOL antagonists and considerably higher than that of the standard GABAA antagonist SR 95531.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17375905     DOI: 10.1021/jm070038n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Advantages of an antagonist: bicuculline and other GABA antagonists.

Authors:  Graham A R Johnston
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

2.  GABA analogues derived from 4-aminocyclopent-1-enecarboxylic acid.

Authors:  Katherine E S Locock; Graham A R Johnston; Robin D Allan
Journal:  Neurochem Res       Date:  2009-06-02       Impact factor: 3.996

3.  Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site.

Authors:  Michaela Jansen; Holger Rabe; Axelle Strehle; Sandra Dieler; Fabian Debus; Gerd Dannhardt; Myles H Akabas; Hartmut Lüddens
Journal:  J Med Chem       Date:  2008-07-24       Impact factor: 7.446

4.  New insights into the GABA(A) receptor structure and orthosteric ligand binding: receptor modeling guided by experimental data.

Authors:  Tommy Sander; Bente Frølund; Anne Techau Bruun; Ivaylo Ivanov; James Andrew McCammon; Thomas Balle
Journal:  Proteins       Date:  2011-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.